01 1Injectable / Parenteral
02 2Tablet
01 3India
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group
Ingredient(s) : Poly L Lactide
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Ingredient(s) : Poly L Lactide
Dosage Form : Injectable / Parenteral, Tablet
Category : Controlled & Modified Release, Parenteral
Brand : PLLA
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group
Grade : Oral, Parenteral
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactide, Polyethylene Glycol Excipient
Dosage Form : Tablet
Grade : Oral, Parenteral
Ingredient(s) : Poly L Lactide, Polyethylene Glycol Excipient
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : PLLA-PEG
Applications : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Grade : Oral, Parenteral
LOOKING FOR A SUPPLIER?